Cargando…
A constant domain mutation in a patient-derived antibody light chain reveals principles of AL amyloidosis
Light chain (AL) amyloidosis is a debilitating disease in which mutant antibody light chains (LC), secreted by aberrant plasma cell clones, misfold and form insoluble fibrils, which can be deposited in various organs. In the majority of cases, the fibrillar deposits consist of LC variable domains (V...
Autores principales: | Rottenaicher, Georg J., Absmeier, Ramona M., Meier, Laura, Zacharias, Martin, Buchner, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950467/ https://www.ncbi.nlm.nih.gov/pubmed/36823438 http://dx.doi.org/10.1038/s42003-023-04574-y |
Ejemplares similares
-
Molecular mechanism of amyloidogenic mutations in hypervariable regions of antibody light chains
por: Rottenaicher, Georg J., et al.
Publicado: (2021) -
Dissection of the amyloid formation pathway in AL amyloidosis
por: Kazman, Pamina, et al.
Publicado: (2021) -
Light Chain (AL) Amyloidosis: The Journey to Diagnosis
por: McCausland, Kristen L., et al.
Publicado: (2017) -
Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021) -
Light chain (AL) amyloidosis: update on diagnosis and management
por: Rosenzweig, Michael, et al.
Publicado: (2011)